Taxane-platinum combination chemotherapy versus single agent platinum for the first-line treatment of epithelial ovarian cancer

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the benefit and harms of adding a taxane to platinum therapy compared to platinum chemotherapy alone for the primary management of epithelial ovarian, fallopian tube or peritoneal epithelial adenocarcinoma.